Related Experiment Video
Updated: Jul 8, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Molecular basis of autosomal recessive polycystic kidney disease (ARPKD)
Lulu Al-Bhalal1, Mohammed Akhtar
1Department of Pathology and Laboratory Medicine, King Khalid University Hospital Riyadh, Saudi Arabia.
Insights
Autosomal recessive polycystic kidney disease (ARPKD) is a genetic disorder affecting kidneys and liver. Mutations in the PKHD1 gene disrupt fibrocystin/polyductin (FPC) function, leading to cystic changes and disease.
Area of Science:
- Genetics
- Molecular Biology
- Nephrology
Background:
- Autosomal recessive polycystic kidney disease (ARPKD) is a severe genetic disorder impacting kidney and liver function.
- It is characterized by the development of cysts in renal collecting ducts and hepatic bile ducts.
- The condition arises from mutations in the PKHD1 gene, located on chromosome 6p12.
Purpose of the Study:
- To elucidate the role of the PKHD1 gene and its encoded protein, fibrocystin/polyductin (FPC), in the pathogenesis of ARPKD.
- To understand how genetic mutations in PKHD1 lead to the observed cystic phenotype.
- To explore the potential interactions of FPC with other ciliary proteins involved in polycystic kidney disease.
Main Methods:
- Genetic analysis of the PKHD1 gene in patients with ARPKD.
- Molecular characterization of fibrocystin/polyductin (FPC) protein structure and function.
- Investigation of FPC localization within primary cilia of renal tubules and bile ducts.
- Comparative analysis with proteins involved in autosomal dominant polycystic kidney disease.
Main Results:
- The PKHD1 gene encodes fibrocystin/polyductin (FPC), a protein found in primary cilia.
- Genetic mutations in PKHD1 can cause structural and functional abnormalities in FPC.
- These FPC abnormalities are strongly linked to the development of cystic changes in the kidneys and liver characteristic of ARPKD.
- FPC likely plays a crucial role in maintaining organ integrity by modulating cellular functions.
Conclusions:
- Genetic mutations in PKHD1 are the underlying cause of ARPKD.
- Dysfunctional fibrocystin/polyductin (FPC) due to PKHD1 mutations disrupts normal cellular processes, leading to cyst formation.
- FPC's role in primary cilia is vital for kidney and liver structural integrity, and its dysfunction results in ARPKD.
Abstract:
Autosomal recessive polycystic kidney disease (ARPKD) is a serious genetic disease characterized by cystic changes in the collecting ducts of the kidney and bile ducts within the liver. The gene for ARPKD (PKHD1) is located on chromosome 6p12 and encodes a protein called fibrocystin/polyductin (FPC), 1 of many proteins that are normally present at the primary cilia of the renal tubules and intrahepatic bile ducts. The severity of the clinical disease depends on the type of genetic mutations. Although exact function of FPC is not fully known, it is generally felt that like many of the other ciliary proteins, it plays a vital role in maintaining the structural integrity of organs such as kidney and liver, by modulating important cellular functions, including proliferation, secretion, apoptosis, and terminal differentiation. FPC probably works in conjunction with cellular proteins involved in autosomal dominant polycystic kidney disease that is, polycystin-1 and polycystin-2, which are also located in the primary cilia. Genetic abnormalities in PKHD1 may result in structural and functional abnormalities of FPC, leading to cystic phenotype.
More Related Videos
Related Concept Videos
Pedigree Analysis
Chronic Kidney Disease I: Introduction
Nephrons
Aquaporins
Acute Kidney Injury II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

